BMO Capital lowered the firm’s price target on Livent to $20 from $24 and keeps a Market Perform rating on the shares. The analyst cites the company’s Q3 earnings miss and reduced guidance primarily due to continued delays to the Argentine carbonate expansion and amid lower lithium prices and lower lithium multiples.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LTHM: